Challenging outlook for contract manufacturers.
The past decade has seen a rapid expansion of pharma contract services markets that have outpaced pharmaceutical markets, often achieving double digit year-on-year growth.
George Green takes a look at the future for the contract drug manufacturer, and finds a scene not as settled as could be thought.
To download the white paper please fill out the adjacent form.
Posted in Strategy.